Home/Filings/4/0001104659-13-043964
4//SEC Filing

Rombotis Spiro George 4

Accession 0001104659-13-043964

CIK 0001130166other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:30 PM ET

Size

5.1 KB

Accession

0001104659-13-043964

Insider Transaction Report

Form 4
Period: 2013-05-21
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
  • Purchase

    Common Stock, $0.001 par value per share

    2013-05-21$3.00/sh+100,000$300,000268,292 total
Footnotes (1)
  • [F1]The total number of shares of common stock beneficially owned by the Reporting Person has been reduced due to an inadvertent mathematical error in a prior report. Of the shares of common stock reported, 142 shares are held indirectly by Mr. Rombotis through his IRA account and 30,714 shares are represented by unvested restricted stock units.

Documents

1 file

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeother

Related Parties

1
  • filerCIK 0001357396

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:30 PM ET
Size
5.1 KB